Biochemical Markers for Diagnosis of Myocardial Infarction Cardiovascular Block Medical Biochemistry Course Dr. Reem M. Sallam, MD, PhD.

Slides:



Advertisements
Similar presentations
Biochemical Markers for Diagnosis of Myocardial Infarction.
Advertisements

1 Lecture | Dr. Usman Ghani
Early assessment of myocardial injury by joint measurement of TnT-hs and Copeptin (1) J. Teixeira, (2) P. Wotquenne, (2) V. D’Orio, (3) D. Gruson, (1)
Acute coronary syndrome : Risk stratification – markers of myocardial necrosis Paul Calle Emergency Department Ghent University Hospital Belgium.
Isoenzymes and Other Markers Mike Clark, M.D.. Isozymes (also known as isoenzymes) are enzymes that differ in amino acid sequence but catalyze the same.
Myocardial infarction New concepts New definitions.
Biomarkers of myocardial infarction Dr. Mamoun Ahram Cardiovascular system, 2014 Resources: This lecture Hand-outs.
BASIC 12 LEAD ECG INTERPRETATION
1.To study the importance of creatine in muscle as a storage form of energy 2.To understand the biosynthesis of creatine 3.To study the process of creatine.
Creatine Metabolism Energy to Skeletal Muscles Lecture-2.
DR. ABDULRAHMAN AL-AJLAN MYOCARDIAL INFARCTION. Introduction The heart is a muscular organ whose function is pumping of blood around the body. It consists.
Dr Azra Parveen Senior Registrar Medicine. Acute myocardial infarction is the rapid development of myocardial necrosis caused by a critical imbalance.
Myocardial Ischemia, Injury, and Infarction
Clinic Laboratory Tests in Cardiac Disease Prof. Dr. ARZU SEVEN.
Cardiac Markers byN.X.. Cardiac Markers 1. After the loss of integrity of cardiac myocyte membranes, intracellular macromolecules diffuse into the interstitium.
(clinical biochemistry of enzymes)
OnSite Troponin I Rapid Test. Cardiac markers are biomarkers measured to evaluate heart function.biomarkers They are often discussed in the context of.
Lecture 5. Infarction The process by which necrosis results from ischemia is called infarction Ischemic necrosis of myocardial cells is one of the commonest.
بسم الله الرحمن الرحيم.
Cardiac Enzymes By Michael W. Bowers. CK-MB 3hr, peak 12-24hr lasts 1-3 days Troponin 3-12 hrs, peak 12-24hr, lasts 8-21 days Trop-T and 7-14 Trop-I.
Myocardial infarction biomarkers Lecture 5. Cases 1 Middle aged man referred by family doctor to a dermatologist because of extensive yellow papules with.
By : dr. samer zahran. Key words myocardium : heart muscle coronary arteries : three major blood vessels supplying blood and oxygen to the heart muscles.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Enzymes in Clinical Diagnosis
Biochemical Markers of Myocardial Infarction
Evaluation of Cardiac Injury and Function. Introduction CHD, – The most important disease affecting the heart is coronary heart disease ACS, – CHD, can.
CARDIAC BIOMARKERS:. History  1950’s: Clinical reports that transaminases released from dying myocytes could be detected via laboratory testing, aiding.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Biomarkers of myocardial infarction Dr. Mamoun Ahram Cardiovascular system, 2013.
Amino-Terminal Pro-Brain Natriuretic Peptide, Brain Natriuretic Peptide, and Troponin T for Prediction of Mortality in Acute Heart Failure.
ACUTE CORONARY SYNDROMES Part I. Definition Acute coronary syndrome (ACS) describes a spectrum of clinical conditions ranging from ST segment elevation.
Biochemical Investigations In Heart Disaeses
Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department.
Enzymes, Cardiac Markers, Hepatic Tests clinically useful enzymes: tissue sources preanalytical variables affecting enzyme activities isoenzymes myocardial.
Ischaemic Heart Disease CASE A. CASE A: Mr HA, aged 60 years, was brought in to A&E complaining of chest pain, nausea and a suspected AMI.
Myocardial Infarction: Blood tests for diagnosis Dr Esmé Hitchcock CHEMICAL PATHOLOGIST.
Cardiac Function.
>>0 >>1 >> 2 >> 3 >> 4 >> Human Diseases Presentation: Myocardial Infarction (MI) Maria Maqsood.
Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome.
Biochemical Markers of Myocardial Infarction
The percentage of values for cardiac troponin (cTn)T associated with elevated values for a point-of-care assay with less sensitivity and precision: the.
Biochemical Markers for Diagnosis of Myocardial Infarction
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Creatine Metabolism Energy to Skeletal Muscles Lecture-2.
Dr. Manal Basyouni Cardiac Markers 1Dr. Manal Basyouni.
Myocardial Infarction (MI) Prepared by Miss Fatima Hirzallah RNS, MSN,CNS.
Troponin By Julie Moore C Dt204/2.
Cost Containment: Use of Troponin testing in the Inpatient Wards Setting Neal Kaushal, R2 DSR2, May 2013.
Enzymes in the Diagnosis of Pathology
Biochemical Investigations In Heart Disaeses
Biochemical Markers of Myocardial Infarction
Biochemistry MI Biomarkers Important. Extra Information.
CARDIAC TROPONIN ASSAY-UTILITY IN DIAGNOSIS OF ACUTE CORONARY SYNDROME
Cardiac enzymes. 2 – Non enzyme proteins The Troponins
LABORATORY FEATURES OF MYOCARDIAL INFARCTION
Tobias Reichlin, M. D. , Willibald Hochholzer, M. D
Cardiac enzymes 1 – Types, Isoenzymes and structure Lecture NO: 2nd MBBS Dr.Muhammad Ramzan.
Biochemical Markers of Myocardial Infarction
New Risk Factors for Heart Disease
Cardiac Troponin.
Coronary Artery Disease 2
Cardiac enzymes and cardiac proteins
Section A: Introduction
Cardiac enzymes. 2 – Non enzyme proteins The Troponins
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Biochemical Markers of Myocardial Infarction
Cardiac profile test.
Biochemical markers for diagnosis of diseases and follow up
Presentation transcript:

Biochemical Markers for Diagnosis of Myocardial Infarction Cardiovascular Block Medical Biochemistry Course Dr. Reem M. Sallam, MD, PhD.

What is Myocardial Infarction? Myocardial ischemia results from the reduction of coronary blood flow to an extent that leads to insufficiency of oxygen supply to myocardial tissue When this ischemia is prolonged & irreversible, myocardial cell death & necrosis occurs ---this is defined as: myocardial infarction is the death & necrosis of myocardial cells as a result of coronary prolonged & irreversible ischemia

Biochemical Changes in Acute Myocardial Infarction (mechanism of release of myocardial markers) ischemia to myocardial muscles (with low O 2 supply) anaerobic glycolysis increased accumulation of Lactate decrease in pH activate lysosomal enzymes disintegration of myocardial proteins cell death & necrosis release of intracellular contents to blood BIOCHEMICAL MARKERS clinical manifestations (chest pain) ECG changes

Diagnosis of Myocardial Infarction SHOULD depend on THREE items (as recommended by WHO) 1- Clinical Manifestations 2- ECG 3- Biochemical Markers

criteria for ideal markers for myocardial infarction 1- Specific: to myocardial muscle cells (no false positive) 2- Sensitive: - rapid release on onset of attack (diagnose early cases) - so, can detect minor damage - no miss of positive cases (no false negative) 3- Prognostic: relation between plasma level & extent of damage 4- Persists longer: so, can diagnose delayed admission 6- Reliable: procedure depends on evidenced principle 5- Simple, inexpensive: - can be performed anywhere by low costs - no need for highly qualified personnel 7- Quick: low turnaround time

Types of Biochemical Markers for Myocardial Infarction 1- Cardiac Enzymes (isoenzymes): Total CK CK-MB activity CK-MB mass 2- Cardiac proteins: Myoglobin Troponins

Cardiac Enzymes Total CK (sum of CK-MM, CK-MB & CK-BB) non specific to cardiac tissue (available in skeletal ms.) CK-MB (CK-2) activity more specific than total CK BUT: less specific than troponin I (available in sk. Ms) appears in blood: within 4-6 hours of onset of attack peak: hours returns to normal: within days (no long stay in blood) Advantages: - useful for early diagnosis of MI - useful for diagnosis reinfarction Disadvantages: not used for delayed admission (more than 2 days) not 100% specific (elevated in sk.ms damage)

CK-MB mass - appears one hour earlier than CK-MB activity (more sensitive) - So, useful for diagnosis of early cases & reinfarction - BUT: not for diagnosis of delayed admission cases & less specific than troponin I Relative index = CK-MB mass / Total CK X 100 more than 5 % is indicative for MI

Cardiac Proteins Myoglobin cytosolic protein - not specific for cardiac tissue (also in sk.ms. & renal tissue) - appears in blood EARLIER than other markers (within 1-4 hours) So, with high sensitivity - BUT: Returns to normal in 24 hours So, not for delayed admission cases (after one day of onset of attack)

Cardiac Troponins Protein complex located on the thin filament of striated muscles consists of 3 subunits: cTn T, cTnI & cTn C with different structures & functions cTnI & cTnT are used are biomarkers for MI diagnosis Cardiac troponins (cTn) are different from skeletal muscle tropnins So, more specific for MI diagnosis cTnI: 100 % cardiac specific With greater sensitivity for diagnosing minor damage of MI Appears in blood within 6 hours after onset of infarction peak: around 24 hours Disappears from blood after about one week (stays longer) So, useful for diagnosis of delayed admission cases Prognostic marker (relation between level in blood & extent of cardiac damage)

Recommendations for use of biochemical markers for diagnosis of myocardial infarction 1- Recommended for all patients complaining of chest pain (with clinical examination & ECG) 2- Sample Type: plasma Timing: i. on admission ii. serial ( at least every one hour in a period 6-9 hours) should be referenced to admission & onset of pain 3- Test should be with low turnaround time less than one hour (accepted) less than half an hour is preferred 4- Types of Markers used: two types early markers: as Myoglobin: appears in blood early (within less 4 fours) BUT not specific & not persists for long period (less than 2 days) definitive markers: Troponin: appears in blood later than myoglobin (within 6 hours) BUT 100% specific, prognostic & stays longer (one week) 5- Troponin is currently the marker of choice should be available in all cardiac & emergency centers (if not, CK-MB mass is the second choice)

THANK YOU